EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence for gene essentiality in Leishmania using CRISPR

Wen-Wei Zhang iD, Greg Matlashewski iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0316331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Wen-Wei Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Genes, Essential, CRISPR-Cas Systems, Gene Editing, Leishmania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability to determine the essentiality of a gene in the protozoan parasite Leishmania is important to identify potential targets for intervention and understanding the parasite biology. CRISPR gene editing technology has significantly improved gene targeting efficiency in Leishmania . There are two commonly used CRISPR gene targeting methods in Leishmania ; the stable expression of the gRNA and Cas9 using a plasmid containing a Leishmania ribosomal RNA gene promoter (rRNA-P stable protocol) and the T7 RNA polymerase based transient gRNA expression system in promastigotes stably expressing Cas9 (T7 transient protocol). There are distinct advantages with both systems. The T7 transient protocol is excellent for high throughput gene deletions and has been used to successfully delete hundreds of Leishmania genes to study mutant phenotypes and several research labs are now using this protocol to target all the genes in L . mexicana genome. The rRNA-P stable protocol stably expresses the plasmid derived gRNA and has been used to delete or disrupt single and multicopy Leishmania genes, perform single nucleotide changes and provide evidence for gene essentiality by directly observing null mutant promastigotes dying in culture. In this study, the rRNA-P stable protocol was used to target 22 Leishmania genes in which null mutants were not generated using the T7 transient protocol. Notably, the rRNA-P stable protocol was able to generate alive null mutants for 8 of the 22 genes. These results demonstrate the rRNA-P stable protocol could be used alone or in combination with the T7 transient protocol to investigate gene essentiality in Leishmania .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genes, EssentialCRISPR-Cas SystemsGene EditingLeishmaniaRNA, Guide, CRISPR-Cas SystemsGenes, ProtozoanPromoter Regions, GeneticClustered Regularly Interspaced Short Palindromic RepeatsRNA, RibosomalPlasmidsDNA-Directed RNA PolymerasesViral Proteins

Substanzen

RNA, Guide, CRISPR-Cas SystemsRNA, Ribosomalbacteriophage T7 RNA polymeraseDNA-Directed RNA PolymerasesViral Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Wen-Wei Zhang, Greg Matlashewski

Zitieren

APA

Zhang, W. W., & Matlashewski, G. (2024). Evidence for gene essentiality in Leishmania using CRISPR. PLOS ONE. https://doi.org/10.1371/journal.pone.0316331

Vancouver

Zhang WW, Matlashewski G. Evidence for gene essentiality in Leishmania using CRISPR. PLOS ONE. 2024. doi:10.1371/journal.pone.0316331

BibTeX
@article{Zhang2024,
  author = {Zhang, Wen-Wei and Matlashewski, Greg},
  title = {Evidence for gene essentiality in Leishmania using CRISPR},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0316331}
}
Kostenlos starten →